Warning letter
Gambro Dasco S.p.A. Bloodline Division [ARCHIVED]: warning letter of Jul 2, 2009
FDA warning letter 63984 · Center for Devices and Radiological Health
Key facts
| Reference number | 63984 |
|---|---|
| Company | Gambro Dasco S.p.A. Bloodline Division [ARCHIVED] |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Jul 2, 2009 |
| Posted date | Jul 2, 2009 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 803, 803.50(a)(1), 820 |
| Inspection city | Medolla |
| Inspection start date | Feb 9, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: